Parkinson's disease is a progressive brain disorder due to the degeneration of dopaminergic neurons in the substantia nigra. Parkinson's disease is a progressive brain disorder due to the degeneration of dopaminergic neutrons in the SN. The accumulation of aggregated forms of α-synuclein protein into Lewy bodies is one of the characteristic features of this disease although the pathological role of any such protein deposits in causing neurodegeneration remains elusive. Here, the effects of different apolipoprotein E isoforms (apoE2, apoE3, apoE4) on the aggregation of α-synuclein in vitro were examined using thioflavin T assays and also an immunoassay to detect the formation of multimeric forms.
Thioflavin T assay
A ThT stock solution (2.5 mM) was prepared by adding 8 mg ThT to 10 mL phosphate buffer (10 mM phosphate, 150 mM NaCl, pH 7.0), filtered through a 0.2 μm syringe filter, and stored at 5 °C in a foilwrapped tube for not longer than one week. For each experiment, the ThT stock solution was diluted with phosphate buffer to generate the working solution (0.05 mM). In the 'continuous' ThT assay, 15 µl of ThT working solution was mixed with R-α-syn solution and the fluorescence intensity of ThT was monitored by excitation at 440 nm and emission at 482 nm over a 5 day incubation period at intervals of 10 mins. In the 'stopped' ThT assay, the R-α-syn solution was incubated at 37 °C and samples were removed after set incubation time periods prior to the addition of 50 µl of ThT to each sample. The intensity of ThT fluorescence was then measured as before. The mean % aggregation was calculated relative to R-α-syn alone
Immunoassay for measuring oligomeric/polymeric α-synuclein
An ELISA plate was coated by overnight incubation with 1 µg/ml of non-biotinylated anti-α-syn C211 antibody, diluted in 200 mM NaHCO 3 , pH 9.6, containing 0.02% (w/v) sodium azide, at 4 °C overnight.
The wells were then washed 4 times with PBS-T and incubated for 2 h at 37 °C with 200 µl/well of freshly prepared blocking buffer. The plate was washed again with PBS-T, and 100 µl of the sample in each well incubated at 37 °C for 2 h. After washes with PBS-T, 100 µl/well of biotinylated C211 diluted to 1 µg/ml in blocking buffer was added and incubated at 37 °C for 2 h. The plate was washed 4 times with PBS-T and incubated with 100 µ/well of streptavidin-europium for 1 h at RT on a shaker. The plate was washed 4 times with PBS-T and 100 µl of europium enhancer (PerkinElmer Life Sciences Inc. USA) added to each well and the plate incubated for 10 min on a shaker. The time-resolved fluorescence (TRF) assay was performed by using the standard conditions for detection of europium fluorescence (excitation at 340 nm, and fluorescence emission at 615 nm) in a Perkin Elmer Wallac Victor2 TM plate reader.
Data analysis
Data are expressed as mean ±SEM, analysed by one-way ANOVA to evaluate the differences between group means. Then, Tukey's HSD method, as a single-step multiple comparison procedure, was used in conjunction with ANOVA (XLSTAT product) to find the mean levels of α-syn aggregation that are significantly different from each other at the four concentrations of each of the different apoE isoforms (p-value < 0.01)
Results
Anion exchange chromatography was effective in the initial purification of the cell lysate to yield R-α-synuclein as the main product (figure 1a) seen on a coomassie blue stained SDS-PAGE Gel. A further purification step using size exclusion chromatography improved the purity of the final R-α-syn to homogeneity as indicated by a single band (figure 1b) on a silver stained SDS-PAGE Gel.
Immunoblotting (figure 1c) using two different α-synuclein specific monoclonal antibodies confirmed the identity.
Two different thioflavin T (ThT) assays were employed to monitor the aggregation of α-syn in the presence of each of the different apoE isoforms. For the 'continuous' assay, R-α-syn, apoE and ThT were simultaneously present throughout the assay, while in the 'stopped' assay R-α-syn was preincubated with apoE prior to addition of ThT for recording fluorescence intensity. This 'stopped' assay method was used to determine whether the presence of ThT has any influence on α-syn aggregation. Statistical analysis was performed using Tukey's HSD method.
In the continuous ThT assay, the lower concentrations of apoE tested (1, 5 and 15 nM) consistently increased the aggregation of α-syn (which was present at 50 μM) whereas the highest concentration of apoE (50 nM) inhibited α-syn aggregation ( Figure 2 ). In all cases, the aggregation typically proceeded ( Figure 2a ) with a time delay of at least 24 h, reflecting the need for a nucleation process. This was followed by biphasic behaviour, exhibiting a slow aggregation phase in the next 36 h eventually leading to a rapid aggregation process at 60-80 h. The length of the nucleation phase was not greatly affected by the presence of apoE, suggesting that apoE does not have any major influence on the onset of α-syn aggregation. The main effect of apoE was to enhance or inhibit the level of the ThT fluorescence signal seen towards the end of the incubation period, which reflects the final number of fibrils formed. The aggregation process approached completion by 120 h, which was taken as the end point. Figure 2b presents the percentage of α-syn aggregation (relative to R-α-syn alone) at the end of this 120 h incubation, in the presence of the different apoE isoforms. A small differential effect was seen for the different isoforms, with the lowest concentration of apoE4 (1 nM) having the greatest stimulatory effect on α-syn fibril formation.
In the stopped ThT assay, the ThT signal seen at the end of the time course (120 h), reflecting the amount of α-syn fibrils formed, was increased in the presence of low concentrations of apoE (15 nM or less) and decreased at the highest apoE concentration (50 nM) ( Figure 3 ). The kinetics of the aggregation in the absence of ThT exhibited a similar biphasic profile to that observed in the presence of ThT for all of the isoforms, as illustrated by apoE2 ( Figure 3a) . Analysis of the final percentage (at 120 h incubation) of α-syn aggregation (figure 3b) in the presence of the different apoE isoforms, relative to R-α-syn alone, confirms that apoE4 has the greatest stimulatory effect on α-syn aggregation at 1 nM apoE concentration.
As can be seen in Figures 2 and 3, apoE4 at 1 nM concentration significantly increases the aggregation of α-syn relative to the other isoforms in both types of ThT assay.
In an attempt to verify these results, an alternative method was employed to monitor α-syn aggregation.
The same samples from the stopped ThT assay were also analyzed by an immunoassay technique for determination of multimeric α-syn. This involves capture of α-syn aggregates with C211 anti-α-syn antibody followed by detection with a biotinylated form of the same antibody. Monomeric α-syn does not
give a signal in this assay [25] . The data from this experiment are presented in Figure 4 , which also includes an overall summary (figure 4d) of the effect of each apoE isoform. The results from this assay were very similar to those obtained with both of the ThT assays. The kinetic profiles (Figure 4a -c) were also comparable to those observed with both of the ThT assays (Figure 2 and 3) . The ThT assay specifically detects β-pleated structures, whereas the sandwich immunoassay is not expected to distinguish between different secondary structures present in the aggregate but selects for any of the multimeric forms. At low apoE concentrations, the rank order (figure 4d) for stimulation of α-syn aggregation was always apoE4>apoE3>apoE2.
All of the data from these three assays are consistent with each other and confirm that apoE4 has the greatest stimulatory effect on α-syn aggregation, at low apoE concentrations. Tukey's HSD test confirms (Figures 2b, 3b, and 4d) that the stimulatory effect of apoE4 is always significantly greater than that of the other isoforms at 1 nM (indicated by the different letters 'a' and 'b'), but the effects of the apoE isoforms are not always significantly different from each other at the higher concentrations (marked by bars with the same letter 'a'). The average of the percentage α-syn aggregation over all three assays, as determined at the end of the incubation time course, has been plotted for each apoE concentration ( Figure 5 ). Here, the data for apoE2, apoE3 and apoE4 have also been combined, so that the overall effects of different concentrations of apoE on α-syn aggregation can be appreciated. The results clearly show that low concentrations of apoE stimulate α-syn aggregation, whereas the highest concentration causes some inhibition.
Discussion
In this study, we examined the effects of each isoform of apoE on the aggregation of recombinant α-syn (R-α-syn) in vitro. For this purpose, we established two different ThT assays (for detection of β-pleated sheet fibrils) and an immunoassay (for detection of multimeric α-syn). The data from all these assays were in remarkably close agreement, and show that low concentrations of apoE increase the amount of late-stage aggregates formed, with apoE4 having the greatest effect, in contrast to higher concentrations of apoE, which inhibit α-syn aggregation.
One possible explanation for these effects of apoE is that it can also self-aggregate, with apoE4 doing so at a faster rate than the other isoforms, and apoE2 aggregating the slowest [26] . If the aggregated form of apoE acts as a 'nucleus' for α-syn aggregation, this could explain why apoE4 appears to enhance aggregation to a greater degree than the other isoforms. Under appropriate conditions, apoE could selfaggregate, or co-aggregate with α-syn, and so act as a 'seed' for other α-syn molecules to become incorporated into the resulting β-sheet aggregates. However, this idea conflicts with the fact that apoE self-aggregation is more closely related to α-helical interactions than the formation of β-sheet structures [26] and so might not be expected to 'seed' β-sheet formation. Also, this type of mechanism cannot easily explain why the highest concentration of apoE actually inhibited α-syn aggregation.
It is also possible that α-syn interacts directly with apoE, with the three isoforms of the latter having differential binding properties, and this could also explain the effects seen on α-syn aggregation. It is interesting to note that apoE has been reported to bind directly to intermediate aggregates or 'oligomers' of the β-amyloid peptide (Aβ) associated with Alzheimer's disease, with apoE4 having the greatest affinity for such binding [27] . Given the fact that Aβ and α-syn both have the ability to form highly similar β-pleated sheet structures, which can even be recognised by the same monoclonal antibody [9] , it would not be surprising if apoE also had the ability to bind to oligomeric α-syn. The kinetic profiles follow a similar pattern for all three assays, and so it can be argued that the aggregation predominately results in the formation of β-pleated sheet structures. Furthermore, as the onset of aggregation was detected at similar time points for all three assays, it could be inferred that in the nucleation phase any small seed structures present must be loosely associated monomeric forms of α-syn and free of the more strongly associated β-pleated sheet.
Among the different apoE isoforms, low concentrations of apoE4 were found to stimulate α-syn aggregation to a greater extent than the other isoforms. This effect of apoE4 on α-syn aggregation could help to explain why apoEε4 is a risk factor for earlier onset of PD [24] , which certainly warrants further investigation.
Taken together, the results from this study have revealed that a possible direct molecular interaction between soluble α-syn and various apoE isoforms can influence the extent of α-syn aggregation in vitro.
A close agreement between the ThT assays and the results from the immunoassay underpins the fact that the α-syn species being detected were oligomeric in nature. Such oligomeric forms are well reported to be neurotoxic [28] . Post-mortem ventricular CSF of individuals [32] , without evidence of dementia or parkinsonism, has an apoE content of around 6.9 µg/ml compared to a lower value of 5.7 µg/ml for PD group. The highest concentration (50 nM) we tested is between 3 to 4 to fold below such levels but caused suppression of α-synuclein aggregation. However in the lower nM range (<50 nM) the aggregation was stimulated indicating unusually low levels of ApoE may potentially contribute in early seeding of the deposition of oligomeric forms of the α-synuclein. Lower apoE levels in the CSF of a PD animal model relative to normal animals have been documented [33] . In a transgenic mouse model of α-synuclein the deletion of apoE expression also decreased the levels of insoluble, in favour of soluble, α-synuclein and slowed the neurodegeneration [20] . The absolute intraneuronal levels of apoE in PD group are probably a more important consideration but unknown. The mechanism of how apoE, at very low levels, could contact the cytoplasmic α-synuclein is obscure. At present, evidence is lacking in the literature to support the view that the α-syn and apoE can interact directly in vivo. One of the main reasons for this is the fact that α-syn has been thought historically to be a cytoplasmic protein, whereas apoE is extracellular. However, it is now clear that extracellular forms of α-syn do exist [29] , and could be involved in a 'prion-like' seeding mechanism for the spread of α-syn pathology to adjacent parts of the brain [30] . Thus extracellular interactions between α-syn and apoE could influence the aggregation of the former, and have an effect on PD pathogenesis. Also, it is feasible that an internalisation mechanism for apoE may bring the two molecules together. In this context, it is interesting to note that altered neuronal apoE trafficking has been implicated to occur in PD and is speculated to be involved in α-syn deposition [18] . Many fundamental questions remain unanswered at this stage due to uncertainties in mechanism of action for the toxicity of oligomeric α-synuclein and technological challenges in studying α-syn aggregation at intracellular level [31] . In our findings, while low levels of apoE aggravated the extent of α-syn aggregation, the higher level tended to supress aggregation. Neurodegeneration induced by overexpressed α-syn in transgenic mice also caused higher levels of apoE [20] . 
